|
|
|
|
|
-
Friday, June 13, 2025
1:12:35 PM HKT
|
|
|
| Press Releases |
|
 |
|
| Friday, February 5, 2021 |
|
|
诺辉健康商业前景可观 长期投资价值极佳 |
| 香港特区政府2018年正式启动的大肠癌筛查先导计划现已进入第三阶段。此计划旨在为50至75岁没有大肠癌症状的香港居民提供筛查资助，以预防大肠癌。据香港卫生署署长陈汉仪介绍，在2011年及2013年，大肠癌已超越肺癌成为全香港最常见的癌症。 more info >> |
|
|
諾輝健康商業前景可觀 長期投資價值極佳 |
| 香港特區政府2018年正式啟動的大腸癌篩查先導計劃現已進入第三階段。此計劃旨在為50至75歲沒有大腸癌症狀的香港居民提供篩查資助，以預防大腸癌。據香港衛生署署長陳漢儀介紹，在2011年及2013年，大腸癌已超越肺癌成為全香港最常見的癌症。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 12:46: JST
|
|
|
TRENDE Announces Strategic Capital and Business Alliance with Tokyu Land
Jun 13, 2025 13:00 JST
|
|
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 11:46 HKT/SGT
|
|
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT/SGT
|
|
|
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
Jun 12, 2025 20:58 HKT/SGT
|
|
|
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
Jun 12, 2025 20:48 HKT/SGT
|
|
|
品質基石的守護者：檢測檢驗行業賦能高質量發展
Jun 12, 2025 18:28 HKT/SGT
|
|
|
质量基石的守护者：检测检验行业赋能高质量发展
Jun 12, 2025 18:19 HKT/SGT
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 17:38: JST
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT/SGT
|
|
|
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT/SGT
|
|
|
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT/SGT
|
|
|
10 winners selected at 8th edition of Start-up Express
Jun 12, 2025 12:29 HKT/SGT
|
|
|
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
Jun 12, 2025 09:00: JST
|
|
|
LEGENDARY HUMANITY Announces Strategic Bitcoin Reserves and Enhancements to the VIVI Token Ecosystem
Jun 12, 2025 08:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
| Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
|
|
| |
